Search results for: 'Reagents AND China'

This Frost & Sullivan research service covers the state of the China Healthcare Information Technology Market, examining drivers and restraints for growth, pricing, technology, legislation, demand and geographical trends. In addition, an in-depth analysis of the competitive situation is performed. The market is further divided into two sub segment...

As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (M...

19 Feb 2021  |  North America  |  Market Research

Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

Infographics

×

Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by underst...

The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

The Chinese wound care market is in the growth stage. Growing ageing population and rise in the incidence of lifestyle diseases, coupled with the increase in risk of chronic wounds and in affordability of better quality of wound care products provide the impetus for the Chinese wound care market. Universal coverage of public health insurance scheme...

14 Jan 2019  |  North America  |  Market Research

Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

Infographics

×

Key Issues Addressed

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

Digital pathology, as a carrier of efficient patient care in the form of long-distance telepathology and telemedecine, can support evolving healthcare needs requiring highly differentiated but integrated products and services. Top causes of inhibited growth is that the costs against the return on investments (ROI) weighs more on the side of costs, ...